Kymab Competitors and Similar CompaniesClear all
Kymab's competitors and similar companies include Oncoinvent and QGel.
 Kymab Kymab is a biopharmaceutical company which discovers and develops human monoclonal antibody therapeutics. |  QGel QGel synthetic extracellular matrices mimic the complex physiology of the human body to bring predictability & efficiency to drug discovery & diagnostics. | ||
Founding Date | Founding Date 2009 | Founding Date 2010 | Founding Date 2009 |
Type | Type Private | Type Private | Type Private |
Tags | |||
Locations | Locations Cambridge, GB HQ | Locations Oslo, NO HQ | Locations Lausanne, CH HQ |
Employees | Employees 407% decrease | Employees 442% decrease | Employees 147% decrease |
Funding | |||
Latest funding round | Latest funding round $ 100m (over 9 years ago) | Latest funding round $ 4m (almost 6 years ago) | Latest funding round $ 12m (over 9 years ago) |
Total funding raised | Total funding raised $ 220.4m | Total funding raised $ 29m | Total funding raised $ 12m |
For sources of this data, please see the company profile
View Company Profiles
Oncoinvent
HQ
Oslo, NO
Employees
44↓ 2% decrease
Oncoinvent AS is a privately held Norwegian company established in 2010.
View companyQGel
HQ
Lausanne, CH
Employees
14↓ 7% decrease
QGel synthetic extracellular matrices mimic the complex physiology of the human body to bring predictability & efficiency to drug discovery & diagnostics.
View company